Menopause

Secondary Logo

Journal Logo

Advanced Search

March 2023 - Volume 30 - Issue 3

  • Isaac Schiff, MD
  • 1530-0374
  • 12 issues per year
  • Obstetrics & Gynecology 28/85
  • 3.310


In this issue, Alvisi et al describe a potential mechanism of action of ospemiphene on the vaginal tissue which is to alter the vaginal microbiome. In an accompanying editorial, Mitchell goes into further detail on this subject to explain the relationship between the microbiome and vaginal atrophy. In keeping with the topic of vaginal atrophy, Hickey et al describe a home-based successful ultrasound treatment for the symptoms.

Faubion et al, in a cross-sectional analysis, found that a migraine history was associated with poor sleep in premenopausal women. In perimenopausal women with migraine history, sleep was also influenced by confounding factors such as vasomotor symptoms and anxiety. To follow up on insomnia: in a cross-sectional study of women veterans, a lifetime history of intimate partner violence (IPV) may be associated with clinical insomnia during midlife. Shaver and Woods in the accompanying editorial describe the health implications of IPV and provide recommendations for clinical practice and research.

In previous issues we have published on the long-term effects of pregnancy on the health of the mother and Appiah et al are reassuring in that age of last birth is not necessarily associated with cardiovascular disease mortality.

We hope you will find all the information in this issue of interest.
 

Isaac Schiff, MD, CM
Editor-in-Chief ​


​View all of the video summaries in the Video Gallery​​​​

NAMS Members:

You may continue to access all issues of Menopause via the Member Section of the NAMS website: menopause.org.

Members who want to take advantage of the personalization features that the journal website offers can register today for their online access to Menopause.

Current Issue Highlights

Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1)

Simon, James A.; Anderson, Richard A.; Ballantyne, Elizabeth; More

Menopause. 30(3):239-246, March 2023.

NAMS Practice Pearl

Clinical considerations for menopause and associated symptoms in women with HIV

Looby, Sara E.

Menopause. 30(3):329-331, March 2023.

Endogenous dehydroepiandrosterone and depression in postmenopausal women: a systematic review of observational studies

Hemachandra, Chandima; Davis, Susan R.; Bell, Robin J.; More

Menopause. 30(3):332-340, March 2023.

​​​

        -hosted by Dr Marla Shapiro 

Videos for Professionals
Videos for Consumers

​NAMS Members are invited to subscribe
to the following exclusive e-newsletters

Menopause e-Consult
Practice Pearls​
Not a Member? Join Now

`